2QE-58894-21504
2 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 322 / FL
- Registered
- 2022-05-30
- Relationship
- Child or adolescent in my care
- Guardian
- LTS-47365-77897
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-11
Dose 1 — Pfizer-BioNTechCo-administered: Flu
-
2021-12-02
Dose 2 — Pfizer-BioNTech
-
2022-05-30
Registered in v-safe
-
2022-06-02
Survey response — 6 months, dose 2, dependentMedDRA: COVID-19, Headache, Oropharyngeal pain, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: He caught Covid 19. Sore throat, headache, feverMedDRA releases: 2024-11 · check-in free text available
- 2022-12-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-11 | Pfizer-BioNTech | Flu |
| 2 | 2021-12-02 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 2, dependent
Symptoms: He caught Covid 19. Sore throat, headache, fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release